oral glp 1 agonist Frontiers Current Insights, Advantages and Challenges

The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways

J Neurosci (2012) 32:481220

This has led to pharmacies and companies selling their own versions of this medication

A similar trial under way at Yale University will follow patients for a year, with data expected in 2028.

This becomes particularly important since inflammation in people with obesity may reduce blood-brain barrier integrity 28

Benefits GLP-1 agonists are effective in weight loss as they delay gastric emptying, induce satiety, and decrease food These agents have been successfully studied in obese, non-diabetic patients Weight loss results seen as early as two weeks into treatment Liraglutide especially is shown to be effective for long-term (2 year) weight loss Liraglutide even produces greater weight loss results than orlistat More favorable effects on HbA1c and blood pressure seen with liraglutide vs